Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Virovir 250mg Tablets | 102-Count | VALACYCLOVIR
Pharma

Virovir 250mg Tablets | 102-Count | VALACYCLOVIR

$190

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse VALACYCLOVIR — 250mg per tablet, 102-count pack. Prodrug of acyclovir with 3–5x better oral bioavailability. Treats HSV-1/2, herpes zoster (shingles), CMV prevention. Daily suppressive therapy reduces herpes transmission. Key warning: Dose adjustment in renal impairment. TTP/HUS risk at high doses in immunocompromised. Maintain adequate hydration. Transmission risk reduced but not eliminated with suppressive therapy.

SKU
VES-001557-VIROVIR-250MG-102TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Virovir 250mg (1X6) (VALACYCLOVIR)?

Prodrug of acyclovir with 3–5x better oral bioavailability. Treats HSV-1/2, herpes zoster (shingles), CMV prevention. Daily suppressive therapy reduces herpes transmission.

How it Works

Converted to acyclovir which inhibits viral DNA polymerase and acts as chain terminator. Active only in virus-infected cells — selective and safe.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
VALACYCLOVIR
Dose per Tablet
250MG
Pack Size
102 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Generally well tolerated. Headache, nausea, abdominal pain. At high doses in immunocompromised: thrombotic microangiopathy (rare but serious).

Safety Warnings

Dose adjustment in renal impairment. TTP/HUS risk at high doses in immunocompromised. Maintain adequate hydration. Transmission risk reduced but not eliminated with suppressive therapy. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.